Folger Nolan Fleming Douglas Capital Management Inc. decreased its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 36.0% during the second quarter, according to its most recent filing with the SEC. The firm owned 4,935 shares of the medical equipment provider’s stock after selling 2,775 shares during the period. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in Zimmer Biomet Holdings were worth $634,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of ZBH. Parkside Financial Bank & Trust grew its holdings in shares of Zimmer Biomet Holdings by 2.7% during the 1st quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock worth $102,000 after acquiring an additional 22 shares during the period. Bronfman E.L. Rothschild L.P. grew its stake in shares of Zimmer Biomet Holdings by 25.3% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock worth $106,000 after buying an additional 167 shares during the last quarter. Parallel Advisors LLC grew its stake in shares of Zimmer Biomet Holdings by 20.8% in the 1st quarter. Parallel Advisors LLC now owns 1,157 shares of the medical equipment provider’s stock worth $138,000 after buying an additional 199 shares during the last quarter. IHT Wealth Management LLC grew its stake in shares of Zimmer Biomet Holdings by 28.4% in the 1st quarter. IHT Wealth Management LLC now owns 1,158 shares of the medical equipment provider’s stock worth $139,000 after buying an additional 256 shares during the last quarter. Finally, Sandy Spring Bank grew its stake in shares of Zimmer Biomet Holdings by 1.7% in the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock worth $149,000 after buying an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 85.48% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Zimmer Biomet Holdings, Inc. (ZBH) Shares Sold by Folger Nolan Fleming Douglas Capital Management Inc.” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2017/09/16/zimmer-biomet-holdings-inc-zbh-shares-sold-by-folger-nolan-fleming-douglas-capital-management-inc.html.

In other news, VP Tony W. Collins sold 16,986 shares of the business’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $121.74, for a total transaction of $2,067,875.64. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.07% of the stock is currently owned by insiders.

ZBH has been the topic of several recent research reports. Zacks Investment Research downgraded Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. BMO Capital Markets restated a “buy” rating and issued a $136.00 price target on shares of Zimmer Biomet Holdings in a research note on Tuesday, July 11th. Wells Fargo & Company restated a “market weight” rating on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Morgan Stanley upped their price target on Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a research note on Monday, July 17th. Finally, Stifel Nicolaus restated a “hold” rating and issued a $125.00 price target on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. Zimmer Biomet Holdings has an average rating of “Hold” and an average price target of $136.75.

Zimmer Biomet Holdings, Inc. (ZBH) traded down 0.45% during trading on Friday, hitting $115.47. The stock had a trading volume of 1,626,722 shares. The firm has a 50 day moving average of $114.88 and a 200-day moving average of $120.74. The stock has a market cap of $23.35 billion, a price-to-earnings ratio of 32.89 and a beta of 1.21. Zimmer Biomet Holdings, Inc. has a 12 month low of $95.63 and a 12 month high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last released its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by ($0.02). Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The firm had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.95 billion. During the same period in the prior year, the firm posted $2.02 earnings per share. Zimmer Biomet Holdings’s revenue for the quarter was up 1.1% compared to the same quarter last year. Equities analysts predict that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 0.83%. The ex-dividend date of this dividend is Thursday, September 21st. Zimmer Biomet Holdings’s dividend payout ratio is currently 27.59%.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Stock Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related stocks with our FREE daily email newsletter.